Ki-67 is an important therapeutic target for cancer, as it is overexpressed in malignant cells but rarely detected in normal cells, and hence its expression is commonly used as a prognostic marker to predict the response of some patients towards specific treatments84–86. The gene discussed is MKI67; the disease is cancer.